Weiss Multi Strategy Advisers LLC Sangamo Therapeutics, Inc Transaction History

Weiss Multi Strategy Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $138,920 - $273,627	-15,051 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $36,966 - $49,183	-3,941 Reduced 20.75%	15,051 $142,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $4,024 - $7,665	648 Added 3.53%	18,992 $170,000
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $58,862 - $103,155	-11,656 Reduced 38.85%	18,344 $117,000
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $262,500 - $390,900	30,000 New	30,000 $323,000
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $139,000 - $198,000	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $334,000 - $527,000	-20,000 Reduced 66.67%	10,000 $190,000
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $232,000 - $347,000	-20,000 Reduced 40.0%	30,000 $492,000
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $420,000 - $750,000	50,000	50,000 $750,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $307M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.